Parkin disrupts the α-synuclein/dopamine transporter interaction

Consequences toward dopamine-induced toxicity

Anna Moszczynska, Jumana Saleh, Hongyu Zhang, Brian Vukusic, Frank J S Lee, Fang Liu

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Parkinson's disease is characterized by progressive neuronal degeneration of dopaminergic neurons in the substantia nigra. Many factors are thought to contribute to the neuronal cell death that occurs in Parkinson's disease, including α-synuclein-mediated toxicity. Previously, we have reported that α-synuclein directly couples to the carboxyl tail of the dopamine transporter (DAT) and that the α-synuclein/DAT protein complex formation accelerates DAT-mediated cellular dopamine (DA) uptake and DA-induced cellular apoptosis. In the present study, we report that parkin, an E2-dependent E3 protein ubiquitin ligase associated with recessive early onset Parkinson's disease, exerts a protective effect against DA-induced α-synuclein- dependent cell toxicity. Parkin impairs the α-synuclein/DAT coupling by interacting with the carboxyl-terminus of the DAT and blocks the α-synuclein-induced enhancement in both DAT cell surface expression and DAT-mediated DA uptake. Moreover, we have found that parkin protects against DA-induced cell toxicity in dopaminergic SK-N-SH cells. These findings will help identify the role of these proteins in the etiology and/or maintenance of Parkinson's disease.

Original languageEnglish
Pages (from-to)217-227
Number of pages11
JournalJournal of Molecular Neuroscience
Volume32
Issue number3
DOIs
Publication statusPublished - Jul 2007

Fingerprint

Synucleins
Dopamine Plasma Membrane Transport Proteins
Toxicity
Dopamine
Parkinson Disease
Ubiquitin-Protein Ligases
Dopaminergic Neurons
Substantia Nigra
Cell death
Neurons
Cell Death
Maintenance
Apoptosis

Keywords

  • α-Synuclein toxicity
  • Dopamine toxicity
  • Dopamine transporter
  • Parkin
  • Parkinson's disease
  • Protein/Protein interactions

ASJC Scopus subject areas

  • Neuroscience(all)
  • Biochemistry
  • Genetics

Cite this

Parkin disrupts the α-synuclein/dopamine transporter interaction : Consequences toward dopamine-induced toxicity. / Moszczynska, Anna; Saleh, Jumana; Zhang, Hongyu; Vukusic, Brian; Lee, Frank J S; Liu, Fang.

In: Journal of Molecular Neuroscience, Vol. 32, No. 3, 07.2007, p. 217-227.

Research output: Contribution to journalArticle

Moszczynska, Anna ; Saleh, Jumana ; Zhang, Hongyu ; Vukusic, Brian ; Lee, Frank J S ; Liu, Fang. / Parkin disrupts the α-synuclein/dopamine transporter interaction : Consequences toward dopamine-induced toxicity. In: Journal of Molecular Neuroscience. 2007 ; Vol. 32, No. 3. pp. 217-227.
@article{06fa7f44184f4b32af0ef67eace61b1b,
title = "Parkin disrupts the α-synuclein/dopamine transporter interaction: Consequences toward dopamine-induced toxicity",
abstract = "Parkinson's disease is characterized by progressive neuronal degeneration of dopaminergic neurons in the substantia nigra. Many factors are thought to contribute to the neuronal cell death that occurs in Parkinson's disease, including α-synuclein-mediated toxicity. Previously, we have reported that α-synuclein directly couples to the carboxyl tail of the dopamine transporter (DAT) and that the α-synuclein/DAT protein complex formation accelerates DAT-mediated cellular dopamine (DA) uptake and DA-induced cellular apoptosis. In the present study, we report that parkin, an E2-dependent E3 protein ubiquitin ligase associated with recessive early onset Parkinson's disease, exerts a protective effect against DA-induced α-synuclein- dependent cell toxicity. Parkin impairs the α-synuclein/DAT coupling by interacting with the carboxyl-terminus of the DAT and blocks the α-synuclein-induced enhancement in both DAT cell surface expression and DAT-mediated DA uptake. Moreover, we have found that parkin protects against DA-induced cell toxicity in dopaminergic SK-N-SH cells. These findings will help identify the role of these proteins in the etiology and/or maintenance of Parkinson's disease.",
keywords = "α-Synuclein toxicity, Dopamine toxicity, Dopamine transporter, Parkin, Parkinson's disease, Protein/Protein interactions",
author = "Anna Moszczynska and Jumana Saleh and Hongyu Zhang and Brian Vukusic and Lee, {Frank J S} and Fang Liu",
year = "2007",
month = "7",
doi = "10.1007/s12031-007-0037-0",
language = "English",
volume = "32",
pages = "217--227",
journal = "Journal of Molecular Neuroscience",
issn = "0895-8696",
publisher = "Humana Press",
number = "3",

}

TY - JOUR

T1 - Parkin disrupts the α-synuclein/dopamine transporter interaction

T2 - Consequences toward dopamine-induced toxicity

AU - Moszczynska, Anna

AU - Saleh, Jumana

AU - Zhang, Hongyu

AU - Vukusic, Brian

AU - Lee, Frank J S

AU - Liu, Fang

PY - 2007/7

Y1 - 2007/7

N2 - Parkinson's disease is characterized by progressive neuronal degeneration of dopaminergic neurons in the substantia nigra. Many factors are thought to contribute to the neuronal cell death that occurs in Parkinson's disease, including α-synuclein-mediated toxicity. Previously, we have reported that α-synuclein directly couples to the carboxyl tail of the dopamine transporter (DAT) and that the α-synuclein/DAT protein complex formation accelerates DAT-mediated cellular dopamine (DA) uptake and DA-induced cellular apoptosis. In the present study, we report that parkin, an E2-dependent E3 protein ubiquitin ligase associated with recessive early onset Parkinson's disease, exerts a protective effect against DA-induced α-synuclein- dependent cell toxicity. Parkin impairs the α-synuclein/DAT coupling by interacting with the carboxyl-terminus of the DAT and blocks the α-synuclein-induced enhancement in both DAT cell surface expression and DAT-mediated DA uptake. Moreover, we have found that parkin protects against DA-induced cell toxicity in dopaminergic SK-N-SH cells. These findings will help identify the role of these proteins in the etiology and/or maintenance of Parkinson's disease.

AB - Parkinson's disease is characterized by progressive neuronal degeneration of dopaminergic neurons in the substantia nigra. Many factors are thought to contribute to the neuronal cell death that occurs in Parkinson's disease, including α-synuclein-mediated toxicity. Previously, we have reported that α-synuclein directly couples to the carboxyl tail of the dopamine transporter (DAT) and that the α-synuclein/DAT protein complex formation accelerates DAT-mediated cellular dopamine (DA) uptake and DA-induced cellular apoptosis. In the present study, we report that parkin, an E2-dependent E3 protein ubiquitin ligase associated with recessive early onset Parkinson's disease, exerts a protective effect against DA-induced α-synuclein- dependent cell toxicity. Parkin impairs the α-synuclein/DAT coupling by interacting with the carboxyl-terminus of the DAT and blocks the α-synuclein-induced enhancement in both DAT cell surface expression and DAT-mediated DA uptake. Moreover, we have found that parkin protects against DA-induced cell toxicity in dopaminergic SK-N-SH cells. These findings will help identify the role of these proteins in the etiology and/or maintenance of Parkinson's disease.

KW - α-Synuclein toxicity

KW - Dopamine toxicity

KW - Dopamine transporter

KW - Parkin

KW - Parkinson's disease

KW - Protein/Protein interactions

UR - http://www.scopus.com/inward/record.url?scp=35348816727&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348816727&partnerID=8YFLogxK

U2 - 10.1007/s12031-007-0037-0

DO - 10.1007/s12031-007-0037-0

M3 - Article

VL - 32

SP - 217

EP - 227

JO - Journal of Molecular Neuroscience

JF - Journal of Molecular Neuroscience

SN - 0895-8696

IS - 3

ER -